|Previous Section||Index||Home Page|
Mr. Burstow: To ask the Secretary of State for Health pursuant to the answer of 6 June 2005, Official Report, column 414W, on Alzheimer's, if she will place in the Library copies of the background papers concerning the reviews to which she refers. 
Only limited papers are readily available about past reviews that looked at the list of medical conditions that give exemption from prescription
30 Jun 2005 : Column 1749W
charges. The cost of searching for all available papers would be disproportionately expensive. The readily available information will be placed in the Library.
An internal review of prescription charges was undertaken by Departmental officials in conjunction with Her Majesty's Treasury as part of the formulation of Government policy for the 1998 comprehensive spending review. This work fed into the outcome of the comprehensive spending review, which was published by Her Majesty's Treasury, pursuant to the answer of 2 February 2005, Official Report, column 908W.
Further information can be found in the statistical bulletin, Ambulance services, England: 200405". Copies are available in the Library and on the Department's website at: http://www.dh.gov.uk/assetRoot/04/ll/36/79/04113679.pdf
Mr. Havard: To ask the Secretary of State for Health how many (a) medical devices and (b) pharmaceutical products were submitted for appraisal to the (i)National Institute for Clinical Excellence in (A) 2003 and (B) 2004 and (ii) National Institute for Health and Clinical Excellence in 2005. 
Jane Kennedy: Details of the appraisal topics referred to the National Institute for Clinical Excellence in 2003 and 2004 and to the National Institute for Health and Clinical Excellence in 2005 are as follows.
Mr. Havard: To ask the Secretary of State for Health (1)if she will ask the National Institute for Health and Clinical Excellence to look at ways to speed up its appraisal process; and if she will make a statement; 
Jane Kennedy: The National Institute for Health and Clinical Excellence (NICE) is an independent organisation, which develops its guidance after careful consideration of the available evidence and in consultation with stakeholders. The process by which it develops its guidance is a matter for NICE. Its processes have been developed through wide consultation, are transparent and have been endorsed by the World Health Organisation. NICE reviews its processes regularly in order to identify opportunities for efficiencies in the way they are applied.
|Next Section||Index||Home Page|